首页> 外文期刊>Journal of Radioanalytical and Nuclear Chemistry: An International Journal Dealing with All Aspects and Applications of Nuclear Chemistry >Gold nanoparticles for Tc-99m-doxorubicin delivery: formulation, in vitro characterization, comparative studies in vivo stability and biodistribution
【24h】

Gold nanoparticles for Tc-99m-doxorubicin delivery: formulation, in vitro characterization, comparative studies in vivo stability and biodistribution

机译:用于TC-99M-Doxorubicin递送的金纳米粒子:制剂,体外表征,体内稳定性和生物分布的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

The [Tc-99m]Tc-Doxorubicin-Gold Nanoparticles (Tc-99m-Dox-AuNPs) was formulated as a nanoradiopharmaceutical by different loading procedures to enhance tumor targeting. The formula F1 that was prepared by direct loading of pre-prepared [Tc-99m]Tc-Doxorubicin showed a reasonable in-vitro characterization values, high entrapment efficiency (92 +/- 0.72%), acceptable in vitro release data and convenient in-vitro serum stability up to 24 h. F1 presented high tumor uptake (54%ID/g) with high Target/ Non Target (T/NT) ( approximate to 77) and Drug Target Efficiency percent (%DTE) above 100% at 0.5 h via intra-tumoral injection that prove the increasing of tumor targeting and in-vivo stability by direct loading for pre-prepared [Tc-99m]Tc-Doxorubicin.
机译:[Tc-99m]Tc-阿霉素金纳米颗粒(Tc-99m-Dox-AuNPs)是通过不同的装载程序制成的纳米放射性药物,以增强肿瘤靶向性。通过直接装载预先制备的[Tc-99m]Tc阿霉素制备的配方F1显示出合理的体外表征值,高包封率(92+/-0.72%),可接受的体外释放数据和方便的体外血清稳定性高达24小时。F1表现出高肿瘤摄取率(54%ID/g),高靶/非靶(T/NT)(接近77)和药物靶效率百分比(%DTE)在0.5小时通过瘤内注射超过100%,证明通过直接装载预制备的[Tc-99m]Tc-阿霉素提高了肿瘤靶向性和体内稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号